Kaya, Mehmet Nur, Kılıç, Özlem, Doğan, Abdullah et al. · Cureus · 2023 · DOI
This study looked at whether three groups of patients—those with familial Mediterranean fever (FMF), a type of spinal arthritis (axSpA), or both conditions—experience heightened pain sensitivity and related symptoms like fatigue and fibromyalgia compared to healthy people. Researchers used a questionnaire to measure 'central sensitization,' which is when the nervous system amplifies pain signals. They found that patients with these conditions did score higher on pain sensitivity measures than healthy controls, and chronic fatigue was particularly common in the FMF group.
Central sensitization—the amplification of pain and sensory signals by the nervous system—is relevant to ME/CFS because many ME/CFS patients experience heightened pain sensitivity and potentially share neurobiological mechanisms with these inflammatory conditions. Understanding how central sensitization manifests across different chronic diseases may illuminate shared pathophysiology and inform treatment approaches for ME/CFS patients who often have overlapping symptoms like fatigue, sleep disturbance, and mood changes.
This study does not establish causality; it only shows association between disease status and central sensitization scores. The cross-sectional design cannot determine whether central sensitization develops as a consequence of these diseases or predates them. The study also does not directly investigate ME/CFS patients, so findings may not directly apply to ME/CFS populations.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →